The characteristics described in this table are general. The intra-aortic balloon pump has been excluded since to it does not generate its own volume stroke. *Clinical approval of ECMO is variable ...

After receiving only the fourth US implant of a new-generation, Utah-made ventricular assist device, an Idaho man with heart failure is looking forward to resuming an active life following an ...

Despite major advances in the treatment of heart failure over the past 2 decades improving the natural history of this condition, heart failure continues to be a major source of morbidity and ...

Heart failure is one of the most pressing health challenges of our time, affecting over 64 million people worldwide and driving significant mortality, morbidity, and healthcare costs. As donor heart ...

Mechanical circulatory support systems for the treatment of end-stage heart failure are now available for a wide variety of clinical situations and support times. Extracorporeal membrane oxygenation ...

"This is a landmark event for children suffering from terminal heart failure." Charles D. Fraser, Jr., MD, Texas Children’s Hospital THE WOODLANDS, Tex., and BERLIN, Dec. 16, 2011—The Berlin Heart ...

The Centers for Medicare and Medicaid Services today proposed coverage policy updates regarding artificial hearts and ventricular assist devices for patients with advanced heart failure. The proposed ...

Israeli tech company Leviticus Cardio has created a unique system that allows for wireless charging of a ventricular assist device (VAD). Previously VADs charged via a power cord that runs from the ...

Austin, TX, USA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Left Ventricular Assist Devices Market Size, Trends and Insights By Product (Left ...

Fineheart SA will soon begin a first-in-human study of Flowmaker, its fully implantable left ventricular assist device, in France, after receiving authorization from the French National Agency for the ...

LONDON--(BUSINESS WIRE)--The ventricular assist devices market is poised to grow by USD 943.27 million during 2020-2024, progressing at a CAGR of almost 12% during the forecast period. Request free ...

Connex Biomedical Inc. applied for patent protection for a transcardiac access port affixed and retained post-procedure on the cardiac muscle, such as the ventricular myocardium, and an access port ...